Insoles for Health & Longevity - Quick Reference Sheet

Insoles for Health & Longevity

Created on 09/29/2026 – Quick Reference based on Evidence Review created using AI4L + evidence-mcp / Sonnet 5.5 – Audit

Insoles are removable shoe inserts that cushion or support the foot or add sensation underfoot, used for foot pain, diabetic foot sores, and steadiness. The strongest evidence, from several controlled trials, covers intense training (fewer overuse bone cracks) and heel pain (relief at two to three months, not one year). Evidence for balance, falls, knee arthritis, and back pain is mixed. Known harms are modest and mostly minor. (Full Review)

Protocol

Injury prevention in high-load training
Contoured foot orthoses
Not shock-absorbing insoles; worn through the training period, 7 to 11 weeks in trials
Plantar heel pain
Prefabricated contoured orthoses
Worn for at least 7–12 weeks; customized versions performed similarly at every time point
Diabetic ulcer prevention
Pressure-optimised custom footwear
Evaluated with in-shoe pressure analysis and re-evaluated after 6 months; an earlier trial aimed for about 20% peak-pressure relief
Time to effect
Plantar heel pain
7–12 weeks
Benefit appeared at 7–12 weeks and was absent at 12 months
Diabetic ulcer prevention
12–18 months
Period over which ulcer prevention was assessed
Balance effects
Immediate
Seen in laboratories

Benefits

Contraindications
  • Active foot ulcer, foot infection, or acute Charcot foot (destructive foot deformity in neuropathy)
  • Critical limb ischemia (severely reduced blood flow; toe pressure below 30 millimeters of mercury or ankle-to-arm blood pressure ratio below 0.4) without vascular review
  • Loss of protective sensation (failed 10-gram monofilament test) with rigid custom insoles not fitted or reviewed by a foot specialist
  • Adults over 65 with two or more falls in the past year using textured insoles without a supervised first trial
  • Known allergy to insole materials such as latex or adhesives
Key Interactions
  • Prescription drugs affecting balance or sensation (severity: caution): sedatives (diazepam, zolpidem), neuropathy-causing chemotherapy (paclitaxel, cisplatin)
  • Drugs that thin skin or impair healing (severity: monitor): oral corticosteroids (prednisone), anticoagulants (warfarin, apixaban)
  • Over-the-counter medications (severity: monitor): analgesics (ibuprofen, acetaminophen)
  • Other interventions (severity: caution): shoes with a tight toe box, unloader knee braces

Risk & Side Effects

  • High:
  • Medium: Blisters, arch pain, and shin pain from new orthoses; Slower gait with textured insoles in older fallers
  • Low: Reduced running economy in distance runners; Smaller intrinsic foot muscles with custom orthosis use
  • Speculative: Skin breakdown in feet with reduced sensation; Contact dermatitis from insole materials; Increased kneecap loading with wedged insoles

Monitoring

Marker Target Why
Foot pain rating (0–10 scale) Lowest tolerable; drop of at least 2 points or 30% from baseline Tracks the main symptom target
Protective sensation (10-gram monofilament test) All tested sites felt Detects sensation loss that raises ulcer risk
Peak plantar pressure (in-shoe) At least 20% below baseline; some clinics target under 200 kilopascals Confirms pressure relief works
Ankle-brachial index 1.0–1.3 Screens for reduced leg blood flow before pressure devices
Hemoglobin A1c 4.8–5.4% Diabetes control influences neuropathy and ulcer risk
Timed Up and Go test 10 seconds or less Screens mobility and fall risk
Usual gait speed 1.2 meters per second or faster Predicts function and falls
Single-leg stance time (eyes open) 30 seconds or more under age 70; 15 seconds or more in the 70s Measures balance
Toe and intrinsic foot strength No established target; track change from own baseline Tracks possible disuse with long-term orthosis use

Cadence: About 2 weeks after fitting for comfort and skin checks, 6–12 weeks for pain outcomes, and every 6–12 months for function and device wear; in high-risk diabetic feet, skin and foot checks every 1–3 months with in-shoe pressure re-evaluation about 6 months after fitting

Qualitative Assessment

  • Comfort and skin condition
  • Walking confidence
  • Fall or near-fall frequency
  • Activity tolerance